Skip to main content

Advertisement

Table 2 Characteristics of applied therapy

From: QTc and psychopharmacs: are there any differences between monotherapy and polytherapy

  Group 1 (N = 32) Group 2 (N = 29)
Psychotropic drug Patients in monotherapy Patients in polytherapy
  N of patients dose range (mg/d) N of patients dose range(mg/d)  
      AD used
Antipsychotic      
   Ziprasidone 3 120–160 1 120 map
   Olanzapine 4 10–20 7 5–15 Mir,ven,par,fluo
   Clozapine 1 100 - - -
   Risperidone 3 3–5 1 4 map
   Sulpiride 1 400 3 50–200 ser,clo
   fluophenazine 7 5–8 6 2–15 tia,ser,par,map
   Haloperidol 3 6–15 4 4–15 mir,map,esc,clo
   Promazine - - 4 75–350 tia,ven,map
   Quetiapine - - 2 300–500 par,fluo
   zuclopenthixol - - 1 10 Fluo
      AP used
Antidepressant      
   Mirtazapine 2 30 3 15–30 ol,hal
   Fluvoxamine 1 150 - - -
   Tianeptin 2 37.5 2 37.5 flu,pro,
   Sertraline 2 50–100 2 50 sul,flu
   Venlafaxine 2 37.5–75 4 37.5–150 ol,pro
   Paroxetine - - 4 10–40 Ol,flu,que
   Maprotiline 1 100 7 50–100 zip,ris,flu,hal
   Fluoxetine - - 3 20–40 ol,que,zuc
   escitalopram - - 1 15 Hal
   clomipramine - - 3 25 sul,hal
  1. AD – antidepressant: map-maprotiline, mir-mirtazapine, ven-venlafaxine, par-paroxetine, fluo-fluoxetine, ser-sertraline, clo-clomipramine, tia-tianeptin, esc-escitalopram
  2. AP -antipsychotic: ol-olanzapine, hal-haloperidol, flu-fluophenazine, pro-promazine, sul-sulpiride, que-quetiapine, zip-ziprasidone, ris-risperidone, zuc-zuclopenthixol